Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort
Open Access
- 18 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (2), 123-134
- https://doi.org/10.1093/jnci/djj013
Abstract
Background: Insulin-like growth factor I (IGF-I) appears to play a role in prostate development and carcinogenesis. We investigated whether genetic variation at the IGF1 locus is associated with prostate cancer risk. Methods: We sequenced IGF1 exons in germline DNA from 95 men with advanced prostate cancer to identify missense variants. IGF1 linkage disequilibrium patterns and common haplotypes were characterized by genotyping 64 single-nucleotide polymorphisms (SNPs) spanning 156 kilobases in 349 control subjects. Associations between IGF1 haplotypes and genotypes were investigated among 2320 patients with prostate cancer and 2290 control subjects from the Multiethnic Cohort. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by unconditional logistic regression to determine the association between prostate cancer and IGF1 haplotypes and genotypes. We used permutation testing to correct for multiple hypothesis testing. All statistical tests were two-sided. Results: No IGF1 missense variants were observed. We identified four blocks of strong linkage disequilibrium and selected a subset of 29 tagging SNPs that could accurately predict both the common IGF1 haplotypes and the remaining SNPs. Haplotype analysis revealed nominally statistically significant associations with prostate cancer risk in each of the four haplotype blocks: haplotype 1B (OR = 1.21, 95% CI = 1.04 to 1.40), haplotype 2C (OR = 1.24, 95% CI = 1.06 to 1.44), haplotype 3C (OR = 1.25, 95% CI = 1.03 to 1.50), and haplotype 4D (OR = 1.19, 95% CI = 1.02 to 1.39). Two SNPs—rs7978742 ( Ptrend = .002) and rs7965399 ( Ptrend = .002)—were perfectly correlated (correlation coefficient = 1.0) with one another and also associated with prostate cancer risk. These two SNPs were strong proxies for haplotypes 1B, 2C, 3C, and 4D and could account for the haplotype findings. Permutation testing revealed that a similarly strong result would be observed by chance only 5.6% of the time. Conclusion: Inherited variation in IGF1 may play a role in the risk of prostate cancer.Keywords
This publication has 40 references indexed in Scilit:
- IGF1 (CA)19 Repeat and IGFBP3 -202 A/C Genotypes and the Risk of Prostate Cancer in Black and White MenCancer Epidemiology, Biomarkers & Prevention, 2005
- Genome-wide association studies for common diseases and complex traitsNature Reviews Genetics, 2005
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 StudiesAmerican Journal of Human Genetics, 2004
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- Assessing the impact of population stratification on genetic association studiesNature Genetics, 2004
- “Are We There Yet?”: Deciding When One Has Demonstrated Specific Genetic Causation in Complex Diseases and Quantitative TraitsAmerican Journal of Human Genetics, 2003
- The genetics and genomics of cancerNature Genetics, 2003
- Dietary Changes Favorably Affect Bone Remodeling in Older AdultsJournal of the American Dietetic Association, 1999
- Genetic Dissection of Complex TraitsScience, 1994